Categories
Angie Szumlinski
|
June 5, 2019
CMS Releases Enforcement of Federal Regulations Related to Antipsychotic Medication Utilization Rates
Angie Szumlinski
|
June 3, 2019
Department of Justice Guidance on Evaluating Corporate Compliance Programs
Angie Szumlinski
|
May 31, 2019
CMS Releases Revisions to Appendix Q (Guidance on Immediate Jeopardy)

Angie Szumlinski
|
May 29, 2019
Office of Inspector General – List of Excluded Individuals/Entities: May 2019
Stay informed with Angie’s expert perspective on current clinical challenges, industry trends, and real-world risk insights.
